EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,000 | -44.0% | 26,800 | +12.6% | 0.00% | 0.0% |
| Q1 2018 | $25,000 | 0.0% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $25,000 | -16.7% | 23,800 | -7.8% | 0.00% | 0.0% |
| Q3 2017 | $30,000 | +36.4% | 25,800 | +63.3% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | -37.1% | 15,800 | +14.5% | 0.00% | -50.0% |
| Q1 2017 | $35,000 | +59.1% | 13,800 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $22,000 | -8.3% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $24,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 16,802,500 | $5,209,000 | 0.31% |
| WEDBUSH SECURITIES INC | 20,000 | $6,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 44,270 | $14,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 107,430 | $33,000 | 0.00% |
| MORGAN STANLEY | 5,000 | $2,000 | 0.00% |
| Invesco Ltd. | 10,323 | $3,000 | 0.00% |